Alendronate sodium and Sunitinib malate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alendronate sodium (alendronate sodium) and Sunitinib malate (sunitinib malate). Common drug interactions include abdominal pain lower among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Alendronate sodium and Sunitinib malate. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

On Jul, 13, 2026

18 people who take Alendronate sodium and Sunitinib malate together, and have interactions are studied.

Alendronate sodium and Sunitinib malate drug interactions.

What are the common drug interactions of Alendronate Sodium and Sunitinib Malate, by gender? *:

female:

Abdominal pain lower
Acute hepatic failure
Alanine aminotransferase increased
Arthralgia (joint pain)
Aspartate aminotransferase increased
Bilirubin conjugated increased
Blood bilirubin increased
Blood creatine phosphokinase increased
Blood creatinine increased
Blood urea increased

male:

Asthenia (weakness)
Dizziness
Oral pain
Pulmonary embolism (blockage of the main artery of the lung)
Renal cell carcinoma (a kidney cancer)
Asthma
Blood albumin decreased
Constipation
Death
Face oedema (swelling of face)

What are the common drug interactions of Alendronate Sodium and Sunitinib Malate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Dehydration (dryness resulting from the removal of water)
Disease progression
Oral pain
Pulmonary embolism (blockage of the main artery of the lung)
Renal cell carcinoma (a kidney cancer)
Decreased appetite
Dizziness
Lethargy (tiredness)
Malaise (a feeling of general discomfort or uneasiness)

60+:

Asthenia (weakness)
Fatigue (feeling of tiredness)
Alanine aminotransferase increased
Arthralgia (joint pain)
Aspartate aminotransferase increased
Asthma
Bilirubin conjugated increased
Blood albumin decreased
Blood bilirubin increased
Blood creatine phosphokinase increased

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 38.89%
Renal Cell Carcinoma (a kidney cancer): 5 people, 27.78%
Insomnia (sleeplessness): 4 people, 22.22%
Gastritis (inflammation of stomach): 4 people, 22.22%
Itching: 4 people, 22.22%
Spinal Osteoarthritis (joint cartilage loss in spine): 4 people, 22.22%
Prostate Cancer: 3 people, 16.67%
Hepatic Neoplasm Malignant (liver cancer): 3 people, 16.67%
Malignant Neoplasm Of Islets Of Langerhans (cancer tumour of pancreas): 3 people, 16.67%
High Blood Cholesterol: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Alendronate sodium and Sunitinib malate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously